nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model
|
Kreft, Iris C. |
|
|
210 |
C |
p. 6-11 |
artikel |
2 |
Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review
|
Tang, Xue |
|
|
210 |
C |
p. 70-77 |
artikel |
3 |
Corrigendum to “A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors” [Thromb. Res. 202, June 2021, 52–58]
|
Wang, Li |
|
|
210 |
C |
p. 4-5 |
artikel |
4 |
Editorial Board
|
|
|
|
210 |
C |
p. IFC |
artikel |
5 |
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials
|
Wang, Xinrui |
|
|
210 |
C |
p. 42-52 |
artikel |
6 |
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
|
Innao, Vanessa |
|
|
210 |
C |
p. 91-93 |
artikel |
7 |
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study
|
Fabris, Sonia |
|
|
210 |
C |
p. 67-69 |
artikel |
8 |
Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis
|
Li, Di-huan |
|
|
210 |
C |
p. 53-62 |
artikel |
9 |
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
|
Nielsen, Nathan D. |
|
|
210 |
C |
p. 1-3 |
artikel |
10 |
Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice
|
Simard, C. |
|
|
210 |
C |
p. 20-25 |
artikel |
11 |
Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy
|
Kumano, Osamu |
|
|
210 |
C |
p. 87-90 |
artikel |
12 |
Osimertinib-related venous thromboembolism in non small lung cancer
|
Petrelli, Fausto |
|
|
210 |
C |
p. 63-66 |
artikel |
13 |
Pre-administration of a carboxypeptidase inhibitor enhances tPA-induced thrombolysis in mouse microthrombi: Evidence from intravital imaging analysis
|
Mathews, Nitty Skariah |
|
|
210 |
C |
p. 78-86 |
artikel |
14 |
Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia
|
Xiao, Mengyu |
|
|
210 |
C |
p. 33-41 |
artikel |
15 |
Protein S-Leu17Pro disrupts the hydrophobicity of its signal peptide causing a proteasome-dependent degradation
|
Okada, Kentaro |
|
|
210 |
C |
p. 26-32 |
artikel |
16 |
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018
|
Sonne-Holm, Emilie |
|
|
210 |
C |
p. 12-19 |
artikel |
17 |
Reference values of coagulation assays performed for thrombophilia screening after a first venous thrombosis and their intra-patient associations
|
Gris, Jean-Christophe |
|
|
210 |
C |
p. 94-103 |
artikel |